HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹206 Cr | ₹210 Cr | ₹277 Cr | ₹195 Cr | ₹222 Cr |
What is the latest Net Current Assets ratio of HIKAL ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹206 Cr |
| Mar2024 | ₹210 Cr |
| Mar2023 | ₹277 Cr |
| Mar2022 | ₹195 Cr |
| Mar2021 | ₹222 Cr |
How is Net Current Assets of HIKAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹206 Cr | -1.95 | |
| Mar2024 | ₹210 Cr | -24.32 | |
| Mar2023 | ₹277 Cr | 42.22 | |
| Mar2022 | ₹195 Cr | -12.05 | |
| Mar2021 | ₹222 Cr | - | |
Compare Net Current Assets of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,335.3 Cr | -3.5% | -12.1% | -47.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -3.5% |
-12.1% |
-47.1% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses